AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

Source URL: www.ctueoc.ch

UNIVERSITÄTSKLINIKUM Schleswig-Holstein Immuntherapie des Glioblastoms Sampson et al. - Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor

Source URL: www.neuro.uni-luebeck.de

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Source URL: www.cancer.dk

• Tyrosine kinase receptors
• Peptidase
• Clinical medicine
• Cancer
• Medicine
• Oncogenes
• Tyrosine kinases
• HER2/neu
• Cathepsin B
• Epidermal growth factor receptor
• ErbB
• Cathepsin Z

Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, U

Source URL: lvdmaaten.github.io

• Tyrosine kinase receptors
• Statistics
• Cluster analysis
• Data analysis
• Computational statistics
• Hierarchical clustering
• Network analysis
• Anaplastic lymphoma kinase
• K-means clustering
• Tyrosine kinase
• Dendrogram
• Epidermal growth factor receptor

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

Source URL: www.zailaboratory.com

• Lung cancer
• Clinical medicine
• Cancer
• Tyrosine kinase inhibitors
• Boehringer Ingelheim
• Health
• T790M
• Protein kinase inhibitor
• Epidermal growth factor receptor
• Non-small-cell lung carcinoma
• Targeted therapy

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

Source URL: www.oncodesign.com

• Medicine
• Clinical medicine
• Tyrosine kinase receptors
• Quinazolines
• Epidermal growth factor receptor
• Oncogenes
• Targeted therapy
• Biomarker
• Treatment of cancer
• Positron emission tomography
• Imaging biomarker
• Erlotinib

TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent

Source URL: techtransfer.univie.ac.at

• Chemistry
• Organic chemistry
• Quinazolines
• Cancer
• Amines
• Tyrosine kinase receptors
• Alkynes
• Erlotinib
• Pfizer
• EGFR inhibitors
• Epidermal growth factor receptor
• Tyrosine-kinase inhibitor

Effects of isoflavones on mRNA expression of IGF1, IGF2, EGF and related growth factor receptors in porcine muscle satellite cell cultures

Source URL: www.archanimbreed.com

• Growth factors
• Peptide hormones
• Isoflavones
• Phytoestrogens
• Endocrinology
• Genistein
• Daidzein
• Insulin-like growth factor 1 receptor
• Insulin-like growth factor
• E-selectin
• Epidermal growth factor
• Skeletal muscle

Theranostics 2016, Vol. 6, IssueIvyspring

Source URL: www.thno.org

• Epidermal growth factor receptor
• Oncogenes
• A431 cells

erlotinib and 3a4 substrate, erlotinib cell lines fda erlotinib supllemental. erlotinib dialogo farmaci. erlotinib egfr erlotinib and gefitinib australia erlotinib lung asians. oral therapy erlotinib rash and erlotinib f

Source URL: observantnomad.com

• Quinazolines
• Amines
• Alkynes
• Erlotinib
• Ethers
• Pfizer
• Gefitinib
• Epidermal growth factor receptor
• Genentech
• Pancreatic cancer
• Non-small-cell lung carcinoma
• Epidermal growth factor